Nkarta Therapeutics Funding: $404M Raised, IPO (2020)

Nkarta Therapeutics is based in South San Francisco, CA. It has raised $404M in total funding. Latest round: IPO. Backed by SR One, NEA, Novo Ventures.

Nkarta Therapeutics funding overview

Nkarta Therapeutics is based in South San Francisco, CA. Nkarta Therapeutics has raised $404M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in January 2020. The round record for Nkarta Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include SR One, NEA, Novo Ventures, Novo Holdings. 4 distinct backers are named across the disclosed rounds.

Nkarta Therapeutics at a glance

Total raised
$404M
Latest round
IPO
Latest round date
January 2020
Headquarters
South San Francisco, CA
Notable investors
SR One, NEA, Novo Ventures, Novo Holdings

Frequently asked about Nkarta Therapeutics funding

How much has Nkarta Therapeutics raised?
Nkarta Therapeutics has raised $404M in total disclosed funding across the rounds on record.
Who has invested in Nkarta Therapeutics?
SR One, NEA, Novo Ventures, Novo Holdings are named among the investors backing Nkarta Therapeutics.
What was the latest Nkarta Therapeutics funding round?
The most recent disclosed round is an IPO, announced in January 2020.
Where is Nkarta Therapeutics based?
Nkarta Therapeutics is based in South San Francisco, CA.
When did Nkarta Therapeutics last raise?
The last disclosed Nkarta Therapeutics round closed in January 2020 at IPO.

Round data for Nkarta Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in South San Francisco and backer lists below.

Companies related to Nkarta Therapeutics (35)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026